In 3Q21, the STI saw its narrowest quarterly trading range since 3Q17, generating a 0.2% decline in total return, while the FTSE APAC Index declined 2.5% and the FTSE All-World Index gained 0.1%. RH Petrogas led the price performances of the 100 most actives in September with a 19% gain, while Rex International added 9%.
Of Singapore’s 100 most traded stocks in 2021, the 10 strongest gainers in 3Q21 to 27 Sep all resided outside of the STI, with Frencken, iFAST, Raffles Medical, Starhill Global REIT, PropNex, First Resources, ESR-REIT, OUE Com REIT, UMS and ARA LOGOS Log Trust averaging 18% total returns.
22 of the 150 most traded stocks that have seen a greater than 10-fold increase in daily turnover in the 2021 year-to-date from 2020. The top 10 includes OIO, RH Petrogas, Mecurius Cap, LHN, Kim Heng, Fortress Minerals, Samudera Shipping, Golden Energy, CFM, Grand Venture Technologies, The Place, VCPlus
The 5 strongest stocks of the FTSE ST All-Share Index from 31 July through to 3 Sep included Olam International, Frencken, Yangzijiang Shipbuilding, OUE and Straits Trading. Together the 5 stocks have averaged a 19% total return over the 5 weeks
The ongoing role of technology, manufacturing and trade in driving global growth under COVID-19 constraints saw Shipbuilding, Technology and Agriculture among the strongest Sectors across the globe in August. This also saw Olam International, Frencken, Yangzijiang Shipbuilding, First Resources and UMS lead the 100 stocks in August
The STI ETFs drew significant investor participation in the 10 months from March 2020 through to the end of December 2020, with more than S$900 million of net inflows and amounting to more than half of the combined inflows of the two STI ETFs over the past decade.
Bank stocks were among the strongest industries of the global stock market in 1H21, outpacing broad global benchmarks, alongside the iron and steel, semiconductor and O&G service industries. DBS, OCBC and UOB averaged 19.0% total returns over the 6 months, in-line with the largest global banks by market value.
Among the iEdge SG All Healthcare Index constituents, Medtecs International was recipient to the highest net institutional and net proprietary inflow (S$8.2M) proportionate to market capitalisation (S$505M) in the 2Q21 to 18 June. Index constituents that generated double-digit total returns in 2Q21 to 18 June included First REIT (23%), Riverstone (15%) and Q&M Dental Group (14%)
Founded in 1993, OTS Holdings has established itself as a brand builder and food manufacturing group in the consumer industry with a strong niche in ready-to-eat and ready-to-cook meat products. OTS Holdings operates the flagship brands of “Golden Bridge” and “Kelly’s”.
In May 2021, 21 SGX primary-listed stocks bought back 36 million shares for a total consideration of S$91.1 million. OCBC commenced a new buyback mandate in May, acquiring 4.21 million shares at an average price of S$12.16 per share. The preceding mandate saw OCBC acquire 6.66 million shares which represented 0.15 per cent of its outstanding shares excluding treasury shares.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.